Mark’s professional life revolved around the concept of suturing. After a career as vascular surgeon, he founded Mellon Medical, a company that developed an automated suturing device for vascular surgeons to suture faster and with more precision in challenging vascular procedures. He continued his path as Chief Medical Officer of Microsure. Managing all clinical aspects of a microsurgical robot, that performs on the cusp of what is humanly possible, connecting blood vessels of less than 1 mm in diameter. Today, Mark is the CEO of OctoVascular, a company that is developing a coronary vessel connector to enable cardiac surgeons to perform coronary bypass surgery in a minimally invasive way. With his dual understanding of the medical and technology world, while combining his extensive start- and scale-up experience, he will be able to add value to the team and together transform OctoVascular into a promising new business.